The antimicrobial potential of bacteriophages
Science, Innovation and Technology Committee
Closed
Inquiry
This inquiry is informed by the successful pitch to the Committee’s My Science inquiry. The World Health Organisation has warned that antibiotic resistance (AMR) is one of the biggest threats to global health, food security, and development today, while the Government’s Special Envoy on Antimicrobial Resistance, Dame Sally Davies, has …
Read more
23
Recommendations
10
Conclusions
1
Report
3
Oral sessions
3
Events
Activity timeline 8 events
1 Mar
2024
2024
3 Jan
2024
2024
Report published
26 Apr
2023
2023
Oral evidence
26 Apr
2023
2023
Formal meeting (oral evidence session) · Room 15, Palace of Westminster
15 Mar
2023
2023
Oral evidence
15 Mar
2023
2023
Formal meeting (oral evidence session) · Room 6, Palace of Westminster
8 Feb
2023
2023
Oral evidence
8 Feb
2023
2023
Formal meeting (oral evidence session) · The Grimond Room, Portcullis House
Oral evidence sessions 3 sessions
26 Apr 2023
View on parliament.uk
Panel One; Panel Two
Dr Jonathan Pearce · Medical Research Council
Dr Marc Bailey · Medicines and Healthcare products Regulatory Agency
Dr Morwenna Carrington · Department for Health and Social Care
Dr Tim Jinks · Wellcome Trust
Professor Isabel Oliver · UK Health Security Agency
Professor Mark Sutton · UK Centre for Ecology and Hydrology
Richard Hebdon · Innovate UK
15 Mar 2023
View on parliament.uk
Dr Hans Petter Kleppen · ACD Pharma
Dr Jean-Paul Pirnay · Queen Astrid Military Hospital, Brussels
Dr Mzia Kutateladze · George Eliava Institute of Bacteriophage, Microbiology and Virology
Greg Merril · Adaptive Phage Therapeutics
Naomi Zak · BiomX
Professor Jon Iredell · The Westmead Institute for Medical Research
Professor Robert Schooley · UC San Diego School of Medicine
8 Feb 2023
View on parliament.uk
Dr James Soothill · Great Ormond Street Hospital Laboratory Medicine
Dr Josh Jones · NHS Tayside
Mr David Browning · Fixed Phage LTD
Ms Stephanie Lesage · Oxford Silk Phage Technologies Ltd
Professor Cath Rees · University of Nottingham
Professor Joanne M. Santini · University College London
Professor Martha Clokie · University of Leicester
Reports 1 report · click to expand
| Title | HC No. | Published | Items | Response |
|---|---|---|---|---|
| First Report - The antimicrobial potential of bacteriophages | HC 328 | 3 Jan 2024 | 33 | Responded |
Recommendations & Conclusions
1 result
24
Conclusion
Accepted in Part
First Report - The antimicrobial p…
Good Manufacturing Practice requirements create impasse for UK phage development
One of the major obstacles to phage clinical trials in the UK has been the requirement for GMP phages. However, regulators require that for phages to achieve GMP standards they must themselves have first been subject to clinical trials. This …
Read more
Government Response
The government states that MHRA's draft non-binding advisory guidance will define standards for licensed phages and clarifies that phages for named-patient use require GMP standards but not clinical trials or marketing authorization, thus providing clarity on the described conundrum.
Department for Science, Innovation and Technology
View details